Autophagy related protein 9A increase in hepatitis B virus-associated hepatocellular carcinoma and the role in apoptosis.

The majority of hepatocellular carcinoma (HCC) cases are associated with the hepatitis B virus (HBV) infection. Autophagy related protein 9A (ATG9A) is a transmembrane protein required for autophagosome formation. In order to investigate the role of ATG9A in HBV-associated HCC, ATG9A protein expression was determined in tumor liver tissues and compared with adjacent nontumor tissues from HCC patients with or without HBV infection. In HBV-associated HCC tissues, ATG9A protein level was increased in tumor liver tissues, but not in cases of non-HBV HCC. Our findings suggested that ATG9A might be involved in HBV and cancer cell survival. Therefore, we aimed to analyze the function of ATG9A in HBV replication using RNA interference to evaluate the HBV DNA level using real-time PCR. In the present study, there were no significant differences between shATG9A-transfected HepG2.2.15 cells and the mock control. However, we found that silencing ATG9A affected apoptosis in HepG2.2.15 and HepG2 cell lines. Our results indicated that ATG9A might be partly involved in the survival of HCC. Thus, the inhibition of ATG9A together with other targets might be a potential drug target for HCC treatment. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Core Tip: Autophagy related protein 9A (ATG9A) protein expression was increased in tumor liver tissues compared to adjacent nontumor tissues from hepatocellular carcinoma (HCC) patients with hepatitis B virus infection. We showed that silencing ATG9A increased cell apoptosis of HepG2.2.15 and HepG2 cells. These results suggested that ATG9A protein is involved in the survival of HCC. The inhibition of ATG9A combined with other targets might be a potential drug target for HCC treatment.

TO THE EDITOR

Autophagy related protein 9A (ATG9A) is a transporter membrane molecule required for initial autophagosome formation in the autophagy pathway[1]. ATG9A has been identified as having the function of a stimulator of interferon (IFN) genes (STING)inhibition. A loss of ATG9A results in enhanced assembly of STING/TANK-binding kinase 1 complexes in response to dsDNA, leading to an increase in innate immune responses[2]. Silencing of ATG9A in macrophages increases STING-mediated IFN-β production and promotes cell viability[3]. Our previous study reported that gene and protein expressions of ATG9A were upregulated in HepG2 and HepG2.2.15 cells compared with a THLE-2 hepatic cell line[4]. Thus, in this study we investigated the role of ATG9A in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) tissues. We found that ATG9A protein levels were highly increased in tumor liver tissues in HBV-associated HCC (9 of the 10 sample pairs). In the case of non-HBV HCC, ATG9A protein levels were decreased or slightly increased in tumor liver tissues (Figure 1). Therefore, we hypothesized that HBV induces the upregulation of ATG9A to benefit its replication. To determine the effect of ATG9A on HBV replication, HBV DNA was quantified from shATG9A-transfected cells and compared to mock cells. We observed no significant difference in shATG9A transfected cells (Figure 2).

Figure 1

Quantification of autophagy related protein 9A protein levels from hepatitis B virus-infected hepatocellular carcinoma patients and nonhepatitis B virus hepatocellular carcinoma patients. A: Western blotting with specific antibodies was used to analyze autophagy related protein 9A (ATG9A) protein expression in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) and nonHBV-HCC. Glyceraldehyde-3-phosphate dehydrogenase (GADPH) was used as a protein loading control; B: Graphs showing the intensity band ratio (tumor tissue/adjacent nontumor tissue) quantified using the LI-COR® image system for western blot analysis.

Figure 2

Silencing of autophagy related protein 9A by RNA interference and detection of hepatitis B virus DNA level. A: The western blot method was applied to analyze autophagy related protein 9 (ATG9A) protein levels against a mock treatment (control) and ATG9A knockdown (shATG9A) HepG2.2.15 cells; B: Quantitation of hepatitis B virus (HBV) DNA by real-time PCR. Total purified DNA from mock treatment (mock) and ATG9A knockdown (shATG9A) in HepG2.2.15 cells was amplified using preS1 specific primers. Hepatitis B virus preS1 plasmid was used as standard copy number. Data is shown as mean ± standard error of the four independent experiments. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.

HBV induces autophagy via the HBx protein and is directly involved in starvation-induced autophagy via upregulation of Beclin-1 expression[5]. HBx also binds and activates phosphatidylinositol 3-kinase class III for autophagy induction[6]. Our study showed that overexpression of HBx did not affect ATG9A expression (Figure 3), suggesting that the function of ATG9A may not involve HBV replication or viral clearance.

Figure 3

Quantitative real-time reverse transcriptase-PCR analysis of autophagy related protein 9A mRNA expression in HepG2-GFP and HepG2-HBx transfected cell lines. β-actin was used as an internal control. Data represent the mean ± standard error in the three independent experiments. ATG9A: Autophagy related protein 9A.

Autophagy is involved in tumor progression and tumor suppression. Several studies have shown that HBV induces autophagy for cell survival in an unsuitable environment[7]. In order to search for the effect of ATG9A on apoptosis, we performed flow cytometry in HepG2.2.15 cells and compared against HepG2 cells after ATG9A silencing. We found that silencing ATG9A increased apoptosis in both cell lines (Figure 4), suggesting that ATG9A is involved in cell apoptosis related to HCC.

Figure 4

Apoptosis assays of HepG2 and HepG2.2.15 transfected with sh-autophagy related protein 9A or shNeg (control). A: Cells were transiently transfected with shRNA plasmids for 72 h and then cultured in starvation medium for 4 h; B: Bar graphs showing the percentage of total apoptotic cells detected by Annexin V binding. Data represent the mean ± standard error from the three independent experiments. ATG9A: Autophagy related protein 9A.

In conclusion, we provide information that ATG9A is highly expressed in HBV-associated HCC tissue samples and plays a role in cell apoptosis. Further studies are needed to investigate the mechanism of ATG9A-mediated inhibition of apoptosis in HCC.

ACKNOWLEDGEMENTS

We are grateful to all the patients who participated in this study. We would like to thank Tangkijvanich P and Sirichindakul B for tissue biopsy collection and Hirankarn N for valuable advice.